EpisodicStatinMig. A multicentre, triple blind, placebo controlled, parallel group study of atorvastatin in episodic migraine. EudraCT Number 2022-502176-23-01. Role: Local PI. Sponsor institution: St. Olav’s Hospital, Trondheim, Norway
Chronic StatinMig. A multicentre, triple blind, placebo controlled, parallel group study of atorvastatin in chronic migraine. EudraCT Number 2022-502177-42-02. Role: Local PI. Sponsor institution: St. Olav’s Hospital, Trondheim, Norway
Nurse intervention Trial. Follow-up from headache nurse: An open randomized. REK #2023/554940. Role: Local PI. Sponsor institution: St. Olav’s Hospital, Trondheim, Norway
Interventional, randomized, double-blind, parallel-group, placebo-controlled study of add-on eptinezumab treatment to brief educational intervention for the preventive treatment of migraine in patients with dual diagnosis of migraine and medication overuse headache (RESOLUTION). EudraCT Number 2021-003049-40. Role: Local PI. Sponsor institution: H. Lundbeck A/S
MiBlock Study - Botulinum toxin type A blockade of the sphenopalatine ganglion in treatment-refractory chronic migraine: A randomized, placebo-controlled, triple-blind (blinded statistician), multicentre, parallel group proof-of-concept, phase 3 study. EudraCT Number 2018-004053-24. Role: Sub-PI. Sponsor institution: St. Olav’s Hospital and NTNU, Trondheim
Danelakis A, Kumelj T, Winsvold BS, Bjørk MH, Nachev P, Matharu M, Giles D, Tronvik E, Langseth H, Stubberud A, (2026) Diagnosing migraine from genome-wide genotype data: a machine learning analysis Brain, 149(1), 290-301 DOI 10.1093/brain/awaf172, PubMed 40326299
Faisal F, Poole AC, Danelakis A, Wergeland T, Bjørk M, Khanevski AN, Kristoffersen ES, Kumelj T, Larsen ICK, Lunder OV, Matharu M, Nachev P, Simpson MR, Tronvik E, Vetvik KG, Winsvold BS, Øie LR, Øvrevik AB, Stubberud A(2026) Forecasting migraine with time-series machine learning from mobile health data J Headache Pain, 27(1) DOI 10.1186/s10194-026-02346-7, PubMed 41913100
Strom NI, Verhulst B, Bacanu SA, Cheesman R, Purves KL, Gedik H, Mitchell BL, Kwong AS, Faucon AB, Singh K, Medland S, Colodro-Conde L, Krebs K, Hoffmann P, Herms S, Gehlen J, Ripke S, Awasthi S, Palviainen T, Tasanko EM, Peterson RE, Adkins DE, Shabalin AA, Adams MJ, Iveson MHet al.(2026) Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling Nat Genet, 58(2), 275-288 DOI 10.1038/s41588-025-02485-8, PubMed 41634414
